COVID-19 Drug design and Development

COVID-19 medicate advancement is the inquire about handle to create preventative helpful medicine drugs that would reduce the seriousness of coronavirus illness 2019 (COVID-19). From early 2020 through 2021, a few hundred medicate companies, biotechnology firms, college investigate bunches, and wellbeing organizations were creating restorative candidates for COVID-19 infection in different stages of preclinical or clinical investigate (506 add up to candidates in April 2021), with 419 potential COVID-19 drugs in clinical trials, as of April 2021.

    Related Conference of COVID-19 Drug design and Development

    April 04-05, 2024

    38th International Conference on Immunology

    Madrid, Spain
    May 23-24, 2024

    18th International Conference on European Immunology

    Zurich, Switzerland
    October 24-25, 2024

    5th International Conference on Immunology And Immunotherapy

    Zurich, Switzerland

    COVID-19 Drug design and Development Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in